Lifemd, INC Form 4 insider transactions

Maria E. Stan, Principal Accounting Officer of LifeMD, Inc., reports the acquisition of 20,000 common shares and disposal of 28,125 shares on March 21, 2024, following the vesting of performance shares.

LifeMD's Chief Innovation Officer, Stefan Galluppi, reports acquisition and disposal of company stock following performance share vesting.

LifeMD's Chief Financial Officer, Marc David Benathen, acquired 75,000 shares of common stock on March 21, 2024, due to the vesting of performance shares.

Nicholas Alvarez, Chief Acquisition Officer of LifeMD, Inc., acquired 75,000 shares of common stock on March 21, 2024, due to performance shares vesting.

Naveen Bhatia, a director and consultant of LifeMD, Inc., acquired 750 shares of common stock on March 13, 2024.